Your gift will be matched during December.
*This matching gift offer will match all new gifts and the amount of any increased gifts made to LLS in the last two years. Eligible donations will be matched up to $50,000 per gift, up to a total of $200,000.
LLS devotes the money we raise to the most promising cancer research of our time and we are making progress. Since 2017, we’ve seen more than 35 blood cancer therapies approved by the U.S. Food and Drug Administration) and LLS has helped advance nearly all of them. We have a proven track record in finding cures and ensuring access to treatments. But there is more to be done and we need your help.
Help us celebrate this day of generosity and beginning of the giving season by making a donation.
More than 35 FDA approvals for blood cancer therapies since 2017
More than $1.2 billion invested in cancer research since 1949
$40 million in funding over the past two decades to support two new FDA-approved CAR T-cell immunotherapies
More than 240 visionary scientists around the world supported by LLS research grants
After experiencing a chronic cough, swollen lymph nodes and other unusual symptoms for more than two years, I went into respiratory failure and ended up in the hospital. Shortly after, I was told I had stage 4 Hodgkin lymphoma and the cancer had spread to every single organ of my body.
I underwent intensive treatment right away, which came with unbearable side effects such as hair loss, nausea, bone pain and severe neuropathy. Every morning, I was grateful to wake up. It’s one thing to lose your physical identity during treatment, but being 29-years-old at the time and having to learn how to walk again was the most heartbreaking.
When I finally found out I was in remission, I immediately called my mom and sobbed into the phone, “Mom, I’m in remission. It’s over!” I have my good days and my bad, but I’ve learned what’s important in life – giving back, being true to myself and sharing my story to create awareness.
Donate today to help fund the most pioneering research of our time.